Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip R Kym

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
The Journal of General Physiology|May 27, 2009
TRPA1: the species differenceJun Chen, Philip R Kym
Current Opinion in Investigational Drugs (London, England : 2000)|June 18, 2003
Prospects for obesity treatment: MCH receptor antagonistsChristine A Collins, Philip R Kym
Progress in Medicinal Chemistry|April 24, 2012
TRPV1 antagonists: clinical setbacks and prospects for future developmentMichael E Kort, Philip R Kym
Current Topics in Medicinal Chemistry|June 16, 2011
Analgesic potential of TRPV3 antagonistsRegina M Reilly, Philip R Kym
Temperature (Austin, Tex.)|May 27, 2016
Feeling hot, feeling cold: TRP channels-a great story unfoldsIrina Vetter, Philip R Kym, Arpad Szallasi
European Journal of Pharmacology|March 19, 2013
Targeting TRP channels for pain reliefJill-Desiree Brederson, Philip R Kym, Arpad Szallasi
ACS Medicinal Chemistry Letters|September 17, 2021
Fueling the Pipeline via Innovations in Organic SynthesisEric A Voight, Stephen N Greszler, Philip R Kym
Biochemical Pharmacology|June 2, 2009
Analgesic potential of TRPV1 antagonistsPhilip R Kym, Michael E Kort, Charles W Hutchins
Current Topics in Medicinal Chemistry|September 11, 2008
Lead optimization of melanin concentrating hormone receptor 1 antagonists with low hERG channel activityAndrew S Judd, Andrew J Souers, Philip R Kym
The Journal of Organic Chemistry|June 11, 2002
Novel approach to the zaragozic acids. Enantioselective total synthesis of 6,7-dideoxysqualestatin H5Satoru Naito, Maya Escobar, Philip R Kym, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
The Journal of General Physiology|May 27, 2009
TRPA1: the species differenceJun Chen, Philip R Kym
Current Opinion in Investigational Drugs (London, England : 2000)|June 18, 2003
Prospects for obesity treatment: MCH receptor antagonistsChristine A Collins, Philip R Kym
Progress in Medicinal Chemistry|April 24, 2012
TRPV1 antagonists: clinical setbacks and prospects for future developmentMichael E Kort, Philip R Kym
Current Topics in Medicinal Chemistry|June 16, 2011
Analgesic potential of TRPV3 antagonistsRegina M Reilly, Philip R Kym
Temperature (Austin, Tex.)|May 27, 2016
Feeling hot, feeling cold: TRP channels-a great story unfoldsIrina Vetter, Philip R Kym, Arpad Szallasi
European Journal of Pharmacology|March 19, 2013
Targeting TRP channels for pain reliefJill-Desiree Brederson, Philip R Kym, Arpad Szallasi
ACS Medicinal Chemistry Letters|September 17, 2021
Fueling the Pipeline via Innovations in Organic SynthesisEric A Voight, Stephen N Greszler, Philip R Kym
Biochemical Pharmacology|June 2, 2009
Analgesic potential of TRPV1 antagonistsPhilip R Kym, Michael E Kort, Charles W Hutchins
Current Topics in Medicinal Chemistry|September 11, 2008
Lead optimization of melanin concentrating hormone receptor 1 antagonists with low hERG channel activityAndrew S Judd, Andrew J Souers, Philip R Kym
The Journal of Organic Chemistry|June 11, 2002
Novel approach to the zaragozic acids. Enantioselective total synthesis of 6,7-dideoxysqualestatin H5Satoru Naito, Maya Escobar, Philip R Kym, et al.
Pageof 7